Sparquote Limited
Analysis
Sparquote Limited is a registered charity in England and Wales, based in Edgware. It was registered in January 1983, 43 years ago. Its declared purposes cover general charitable purposes, education/training, the advancement of health or saving of lives and disability, which this site groups under health and saving lives. Legally it is a charitable company (Companies House number 01674021). It says it makes grants to organisations.
In the financial year ending March 2025, Sparquote Limited reported income of £6.6m and spending of £5.3m, spending 81% of its income. Across the 5 years on record, from March 2021 to March 2025, income grew from £1.0m to £6.6m (+528%), an average of +58% a year. The sharpest change came in the year to March 2025, when income rose by 527%. Over the whole period it spent 74% of the income it received.
Among 24,651 England and Wales charities whose main cause is health and saving lives and that reported income, Sparquote Limited sits at the 97th percentile: it is larger than about 97% of them. Against every charity in England and Wales with reported income it ranks in the 98th percentile. Charities of a similar size with the same main cause include Age UK Oxfordshire (£6.5m), International Foundation for AIDS to Navigation (£6.6m) and Eden Valley Hospice, Carlisle (£6.5m).
In its latest detailed accounts, income came from trading 72% and investments 28%. Charitable activities took 28% of spending and raising funds 10%. Reserves of £20.3m would cover about 46 months of spending at that rate.
Income and spending
Where the income comes from
- Trading 72%
- Investments 28%
In the charity's own words
The Charity's principal activity throughout the year was the provision and distribution of donations and grants to charities.
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Age UK Oxfordshire | Oxfordshire | £6.5m |
| International Foundation for AIDS to Navigation | London | £6.6m |
| Eden Valley Hospice, Carlisle | Carlisle | £6.5m |
| Bowel Cancer UK | London | £6.6m |